Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text Full Text (PDF) PPT slides of all figures Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JEM Download to citation manager Citing Articles Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Norrby, E. Search for Related Content PubMed PubMed Citation Articles by Norrby, E. Pubmed/NCBI databases Substance via MeSH Social Bookmarking                      What's this?

Center for the History of Science, The Royal Swedish Academy of Sciences, SE-104 05 Stockholm, Sweden

erling.norrby{at}kva.se

ABSTRACT
In 1951, Max Theiler of the Rockefeller Foundation received the Nobel Prize in Physiology or Medicine for his discovery of an effective vaccine against yellow fever—a discovery first reported in the JEM 70 years ago. This was the first, and so far the only, Nobel Prize given for the development of a virus vaccine. Recently released Nobel archives now reveal how the advances in the yellow fever vaccine field were evaluated more than 50 years ago, and how this led to a prize for Max Theiler.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS